Patents by Inventor Brent R. Copp

Brent R. Copp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5574057
    Abstract: Naamidine A isolated from marine sponges is found to be selective in inhibiting the growth of tumor cells which are dependent upon epidermal growth factor for their growth, while showing acceptably low general cytotoxicity. Such selectivity was established through in vitro and in vivo comparative testing using tumor cells which over express EGF receptor cites. The in vivo tests used nude athymic mice that were implanted with squamous cells carcinoma.
    Type: Grant
    Filed: May 26, 1994
    Date of Patent: November 12, 1996
    Assignee: University of Utah Research Foundation
    Inventors: Chris M. Ireland, Brent R. Copp, Craig R. Fairchild
  • Patent number: 5565486
    Abstract: Sesquiterpenes obtainable from the fungal strain Acremonium strictum XO6/15/458, and phannaceutically and veterinarily acceptable salts thereof, are inhibitors of the binding of benzodiazepine to the GABA-benzodiazepine-Cl ionophore receptor complex. These compounds are prepared by (i) fermenting, in a source of carbon, nitrogen and inorganic salts, fungal strain XO6/15/458 (IMI 354451) or a mutant thereof which produces the sesquiterpenes, (ii) isolating the sesquiterpenes from the fermentation medium; and (iii) if desired, converting the sesquiterpene into a pharmaceutically or veterinarily acceptable salt.
    Type: Grant
    Filed: August 29, 1995
    Date of Patent: October 15, 1996
    Assignee: Xenova Limited
    Inventors: Didier V. Renno, Gerard B. O'Beirne, Brent R. Copp